Diagnostic and therapeutic uses of inhaled nitric oxide in neonatal Ebstein's anomaly

Am J Cardiol. 2003 Apr 1;91(7):906-8. doi: 10.1016/s0002-9149(03)00036-5.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Administration, Inhalation
  • Biomarkers / blood
  • Blood Pressure / drug effects
  • Blood Pressure / physiology
  • Cardiac Surgical Procedures
  • Ebstein Anomaly / diagnosis*
  • Ebstein Anomaly / mortality
  • Ebstein Anomaly / therapy*
  • Echocardiography
  • Follow-Up Studies
  • Heart Rate / drug effects
  • Heart Rate / physiology
  • Humans
  • Hydrogen-Ion Concentration
  • Infant Welfare
  • Infant, Newborn
  • Neonatal Screening*
  • Nitric Oxide / therapeutic use*
  • Nitrogen Dioxide / blood
  • Oxygen / blood
  • Prostaglandins E / therapeutic use
  • Pulmonary Atresia / diagnosis
  • Pulmonary Atresia / mortality
  • Pulmonary Atresia / therapy
  • Pulmonary Circulation / physiology
  • Severity of Illness Index
  • Survival Analysis
  • Treatment Outcome

Substances

  • Biomarkers
  • Prostaglandins E
  • Nitric Oxide
  • Nitrogen Dioxide
  • Oxygen